vs

Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.

Ponce Financial Group, Inc. is the larger business by last-quarter revenue ($31.4M vs $18.8M, roughly 1.7× BIOLIFE SOLUTIONS INC). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs 36.3%, a 22.6% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs 24.3%). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs 1.0%).

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.

BLFS vs PDLB — Head-to-Head

Bigger by revenue
PDLB
PDLB
1.7× larger
PDLB
$31.4M
$18.8M
BLFS
Growing faster (revenue YoY)
PDLB
PDLB
+13.3% gap
PDLB
37.6%
24.3%
BLFS
Higher net margin
BLFS
BLFS
22.6% more per $
BLFS
58.9%
36.3%
PDLB
Faster 2-yr revenue CAGR
PDLB
PDLB
Annualised
PDLB
23.7%
1.0%
BLFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLFS
BLFS
PDLB
PDLB
Revenue
$18.8M
$31.4M
Net Profit
$11.1M
$10.1M
Gross Margin
Operating Margin
7.2%
43.6%
Net Margin
58.9%
36.3%
Revenue YoY
24.3%
37.6%
Net Profit YoY
-11.1%
245.6%
EPS (diluted)
$0.23
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLFS
BLFS
PDLB
PDLB
Q4 25
$18.8M
$31.4M
Q3 25
$28.1M
$26.7M
Q2 25
$25.4M
$26.5M
Q1 25
$23.9M
$24.6M
Q4 24
$15.1M
$22.8M
Q3 24
$21.4M
$20.2M
Q2 24
$19.7M
$20.2M
Q1 24
$18.4M
$20.5M
Net Profit
BLFS
BLFS
PDLB
PDLB
Q4 25
$11.1M
$10.1M
Q3 25
$621.0K
$6.5M
Q2 25
$-15.8M
$6.1M
Q1 25
$-448.0K
$6.0M
Q4 24
$12.5M
$2.9M
Q3 24
$-1.7M
$2.4M
Q2 24
$-20.7M
$3.2M
Q1 24
$-10.2M
$2.4M
Operating Margin
BLFS
BLFS
PDLB
PDLB
Q4 25
7.2%
43.6%
Q3 25
-0.3%
32.8%
Q2 25
-65.5%
30.2%
Q1 25
-5.1%
32.5%
Q4 24
3.6%
19.6%
Q3 24
-2.0%
15.2%
Q2 24
-6.6%
21.8%
Q1 24
-17.9%
18.3%
Net Margin
BLFS
BLFS
PDLB
PDLB
Q4 25
58.9%
36.3%
Q3 25
2.2%
24.3%
Q2 25
-62.3%
23.0%
Q1 25
-1.9%
24.2%
Q4 24
82.5%
14.1%
Q3 24
-8.0%
12.1%
Q2 24
-105.1%
15.8%
Q1 24
-55.4%
11.8%
EPS (diluted)
BLFS
BLFS
PDLB
PDLB
Q4 25
$0.23
$0.43
Q3 25
$0.01
$0.27
Q2 25
$-0.33
$0.25
Q1 25
$-0.01
$0.25
Q4 24
$0.27
$0.11
Q3 24
$-0.04
$0.10
Q2 24
$-0.45
$0.14
Q1 24
$-0.22
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLFS
BLFS
PDLB
PDLB
Cash + ST InvestmentsLiquidity on hand
$33.0M
$126.2M
Total DebtLower is stronger
$5.0M
$596.1M
Stockholders' EquityBook value
$371.9M
$541.5M
Total Assets
$405.9M
$3.2B
Debt / EquityLower = less leverage
0.01×
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLFS
BLFS
PDLB
PDLB
Q4 25
$33.0M
$126.2M
Q3 25
$29.5M
$146.6M
Q2 25
$31.9M
$126.6M
Q1 25
$66.9M
$129.9M
Q4 24
$91.5M
$139.8M
Q3 24
$24.0M
$155.8M
Q2 24
$22.0M
$103.2M
Q1 24
$29.7M
$134.7M
Total Debt
BLFS
BLFS
PDLB
PDLB
Q4 25
$5.0M
$596.1M
Q3 25
$7.5M
$521.1M
Q2 25
$10.1M
$536.1M
Q1 25
$12.9M
$521.1M
Q4 24
$15.9M
$596.1M
Q3 24
$20.1M
$580.4M
Q2 24
$21.1M
$680.4M
Q1 24
$24.3M
$680.4M
Stockholders' Equity
BLFS
BLFS
PDLB
PDLB
Q4 25
$371.9M
$541.5M
Q3 25
$353.7M
$529.8M
Q2 25
$347.2M
$521.1M
Q1 25
$352.6M
$513.9M
Q4 24
$348.9M
$505.5M
Q3 24
$325.5M
$504.6M
Q2 24
$321.4M
$497.7M
Q1 24
$333.4M
$493.7M
Total Assets
BLFS
BLFS
PDLB
PDLB
Q4 25
$405.9M
$3.2B
Q3 25
$392.1M
$3.2B
Q2 25
$387.2M
$3.2B
Q1 25
$395.1M
$3.1B
Q4 24
$399.5M
$3.0B
Q3 24
$381.7M
$3.0B
Q2 24
$375.0M
$2.8B
Q1 24
$401.6M
$2.8B
Debt / Equity
BLFS
BLFS
PDLB
PDLB
Q4 25
0.01×
1.10×
Q3 25
0.02×
0.98×
Q2 25
0.03×
1.03×
Q1 25
0.04×
1.01×
Q4 24
0.05×
1.18×
Q3 24
0.06×
1.15×
Q2 24
0.07×
1.37×
Q1 24
0.07×
1.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLFS
BLFS
PDLB
PDLB
Operating Cash FlowLast quarter
$4.9M
$55.6M
Free Cash FlowOCF − Capex
$54.6M
FCF MarginFCF / Revenue
173.9%
Capex IntensityCapex / Revenue
3.1%
Cash ConversionOCF / Net Profit
0.44×
5.48×
TTM Free Cash FlowTrailing 4 quarters
$74.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLFS
BLFS
PDLB
PDLB
Q4 25
$4.9M
$55.6M
Q3 25
$6.1M
$1.4M
Q2 25
$7.4M
$6.2M
Q1 25
$1.7M
$13.1M
Q4 24
$1.6M
$7.2M
Q3 24
$4.8M
$-14.6M
Q2 24
$6.5M
$-2.6M
Q1 24
$-4.5M
$1.5M
Free Cash Flow
BLFS
BLFS
PDLB
PDLB
Q4 25
$54.6M
Q3 25
$786.0K
Q2 25
$5.9M
Q1 25
$12.9M
Q4 24
$4.5M
Q3 24
$-15.0M
Q2 24
$-2.6M
Q1 24
$-315.0K
FCF Margin
BLFS
BLFS
PDLB
PDLB
Q4 25
173.9%
Q3 25
2.9%
Q2 25
22.4%
Q1 25
52.6%
Q4 24
19.7%
Q3 24
-74.1%
Q2 24
-13.0%
Q1 24
-1.5%
Capex Intensity
BLFS
BLFS
PDLB
PDLB
Q4 25
3.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
0.6%
Q4 24
11.9%
Q3 24
2.0%
Q2 24
0.3%
Q1 24
8.7%
Cash Conversion
BLFS
BLFS
PDLB
PDLB
Q4 25
0.44×
5.48×
Q3 25
9.83×
0.21×
Q2 25
1.01×
Q1 25
2.20×
Q4 24
0.13×
2.46×
Q3 24
-5.99×
Q2 24
-0.80×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons